Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet

N/ANot Yet RecruitingNCT07275125

Sohag University40 enrolled

Overview

To assess clinical outcomes in drug resistant epileptic pediatric patient by modified atkin diet with focusing on following points: 1. Control of seizures(frequency , duration and numbers of hospital admissions) . 2. Quality of life by pediatric quality of life inventory v4. 3. Cognitive function by stanford binet intelligence scale 5th edition. 4. Growth parameters ( weight, height will be combined to report BMI in kg/m\^2).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Drug Resistant Epilepsy

Eligibility

Sex: ALLMin age: 1 YearMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children aged 1-18 years. * Diagnosed with drug-resistant epilepsy according to ILAE definition.\[2\] * On KD for at least 6 months. Exclusion Criteria: * \- Patients with contraindicated metabolic/genetic conditions. * Non-compliance with KD . Patients on alternative dietary therapies (e.g., low glycemic diet)

Locations (1)

Sohag faculty of medicine

Sohag, Egypt

Outcomes

Primary Outcomes

1-Control of seizures(frequency and duration of seizures) . 2-Quality of life by pediatric quality of life inventory v4. 3-Cognitive function by stanford binet intelligence scale 5th edition. 4-Growth parameters (weight and height by BMI in kg/m^2)

Time frame: 6 month

Secondary Outcomes

to detect clinical predictors of seizures control ( frequency of attack and duration) in patients with drug resistant epilepsy using MAD.

Time frame: 6 month

Central Contacts

Mahmoud Saber Elsayed

CONTACT

00201069770585 Mm.ss.elsayed277@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.